Alto Ingredients (ALTO) Misses Q4 EPS by 42c

Alto Ingredients (NASDAQ: ALTO) reported Q4 EPS of ($0.46), $0.42 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $328.4 million versus the consensus estimate of $340.69 million.

For earnings history and earnings-related data on Alto Ingredients (ALTO) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
• Apollo agrees to buy EasyJet Plc. (EZJ:LN) (ESYJY); Bernstein SocGen shares investment implications